scholarly journals Effectiveness of Tuberculous Recombinant Allergen Skin Tests for Detecting Tuberculosis in Children and Adolescents of Moscow in 2013

2015 ◽  
Vol 12 (1) ◽  
pp. 99-103 ◽  
Author(s):  
L.V. Slogotskaya ◽  
◽  
O.Yu. Senchikhina ◽  
G.V. Nikitina ◽  
E.M. Bogorodskaya ◽  
...  
2022 ◽  
Vol 99 (12) ◽  
pp. 33-37
Author(s):  
E. N. Aleksandrova ◽  
T. I. Morozova ◽  
T. Yu. Salina

Subjects and Methods. Incidence and prevalence of tuberculosis among children and adolescents in Saratov Region were retrospectively analyzed for 2015-2019.Results. The incidence of tuberculosis in children reflects general trends in the epidemic situation over the years in Saratov Region. In this region during 10 years of monitoring, tuberculosis incidence among children decreased 4 times by 2019 and it made 2.3 per 100,000 population, and among adolescents, it decreased 1.6 times (16.3 per 100,000 population). The number of children with post-tuberculosis changes detected for the first time increased 3 times in 2019 versus 2015, and the number of adolescents increased 4.5 times not only due to transition to tuberculosis screening in children aged 8-17 years old by skin test with tuberculosis recombinant allergen but also to the examination of children by computed tomography. The incidence in children followed up as Group IVA in 2019 was 15 times higher than this rate in the overall pediatric population. Analysis of the number of children and adolescents who developed tuberculosis and followed up as Groups IV and VI in 2015-2019 showed that the number of children ill with tuberculosis in Group IV was 3 times higher than the number of children in Group VI.


2007 ◽  
Vol 13 (9) ◽  
pp. 1361-1363 ◽  
Author(s):  
Pei-Chun Chan ◽  
Li-Min Huang ◽  
Yi-Chun Wu ◽  
Hsiang-Lin Yang ◽  
I-Shou Chang ◽  
...  

2017 ◽  
Vol 95 (6) ◽  
pp. 34-39 ◽  
Author(s):  
L. A. Bаryshnikovа ◽  
◽  
V. A. Аksenovа ◽  
N. I. Klevno ◽  
◽  
...  

PEDIATRICS ◽  
1960 ◽  
Vol 26 (4) ◽  
pp. 641-653
Author(s):  
A. Lotte ◽  
H. Noufflard ◽  
Robert Debrá ◽  
H. E. Brissaud

A preliminary inquiry of the Institut National d'Hygiéne (France), based on the follow-up of 5,526 cases of primary tuberculosis in children and adolescents, is reported; 1,425 cases were seen before 1955 and included in the statistical survey concluded in June, 1956. The spontaneous course of 895 patients who received no treatment is analyzed; special emphasis is placed on complications and their relative incidence in the different age groups and forms of primary tuberculosis. Comparative studies of treated and untreated cases were possible only in patients under 15 years of age and in clinically manifest forms of tuberculosis (Types II, III, and IV). These cases represent a total of 1,061 cases; 564 patients received treatment, 497 received no treatment. Findings in the different age groups are analyzed. A bacteriologic inquiry was also made on the problem of contamination with streptomycin- and isoniazid-resistant strains of M. tuberculosis and on secondarily acquired resistance to isoniazid in treated patients. A decrease of more than 80% in the incidence of complications led to the conclusion that routine chemotherapy should be resorted to in clinically manifest primary tuberculosis in children and adolescents. In the case of completely latent primary tuberculosis, however, a definite answer cannot be given as yet. It is the purpose of the future development of the trial to try to answer that question.


2020 ◽  
Vol 67 (8) ◽  
Author(s):  
Patricia Obando ◽  
David A. Verón ◽  
Mauricio Castellanos ◽  
Karen S. Fernández

2009 ◽  
Vol 28 (5) ◽  
pp. 416-419 ◽  
Author(s):  
Wanatpreeya Phongsamart ◽  
Ian Kitai ◽  
Michael Gardam ◽  
Jun Wang ◽  
Kamran Khan

2016 ◽  
Vol 11 (4) ◽  
pp. 9-17
Author(s):  
V.A. Aksenova ◽  
◽  
N.N. Moiseeva ◽  
N.I. Klevno ◽  
V.S. Odinets ◽  
...  

2018 ◽  
Vol 20 (3) ◽  
pp. 17-20
Author(s):  
G S Balasanyants ◽  
N V Skotnikova ◽  
V V Dantsev

38 patients with newly diagnosed tuberculosis, immediately after the end of the main course of treatment, when they were transferred to the third group of dispensary supervision (6-9 months) and when they were removed from the dispensary supervision (2-3 years later), a skin test with an allergen tuberculous recombinant was made. The positive skin test with tuberculosis recombinant allergen was defined at 20 patients - 13 mm. At the moment of removing to the III group only one skin test with tuberculosis allergen recombinant became negative, 19 (94,5%) patients had positive reactions - 13±2,3 mm. At the time of discharging from dispensary the positive reactions were determined at 16 (80%) cases - 10±2,3 mm, p0,05. In this group, 13 (65%) patients had normergic skin tests with tuberculosis allergen recombinant and 7 (35%) - hyperergic tests. At the time of removing to the III group at five from seven patients with hyperergic tests the results remained the same, median and at the moment of discharging from tuberculosis service only one patient had the hyperergic skin test with tuberculosis allergen recombinant - 18mm. Among patients with normergic skin tests with tuberculosis allergen recombinant at the time of group III removing median was 11±2,1 mm. At the last dynamic control the normergic results were determined at 15 (75%) patients and the tests median remained almost unchanged - 10±1,8 mm, the differences are reliable compared to the initial data (p0,05). In group which included 18 patients with negative skin tests with tuberculous allergen recombinant, the skin response stayed negative throughout all examination period except for one patient so patients of this group had not only clinical, radiological and bacteriological, but immunological signs of involution of the tuberculosis process. The study of the influence of clinical, epidemic and social factors to skin reaction showed that first group patients were significantly more likely to be unemployed (30% versus 5,5%; p0,05) whereas in second group married patients were reliably registered (61,1% versus 25%; p0,05). Other factors differed unreliably.


Sign in / Sign up

Export Citation Format

Share Document